3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
91
Myelodysplastic Syndromes
26
Leukemia, Myelomonocytic, Chronic
12
Myeloproliferative Disorders
8
Leukemia
6
Hematologic Neoplasms
5
Recurrence
4
Leukemia, Biphenotypic, Acute
4
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Neoplasms
3
Myelodysplastic-Myeloproliferative Diseases
3
Hematologic Diseases
3
Anemia, Refractory, with Excess of Blasts
3
Primary Myelofibrosis
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Polycythemia Vera
2
Lymphoma, T-Cell, Peripheral
2
Lymphoma, T-Cell
2
Leukemia, Neutrophilic, Chronic
2
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
2
Leukemia, Monocytic, Acute
2
Leukemia, Megakaryoblastic, Acute
2
Leukemia, Erythroblastic, Acute
2
Immunoblastic Lymphadenopathy
2
Thrombocytosis
1
Thrombocythemia, Essential
1
Sarcoma, Myeloid
1
Pathologic Complete Response
1
Neurofibromatosis 1
1
Neoplasm Metastasis
1
Interventions
Radiosurgery
31
Magnetic Resonance Spectroscopy
16
Temozolomide
12
pembrolizumab
11
Nivolumab
10
Specimen Handling
8
Ipilimumab
8
Bevacizumab
8
Radiotherapy
7
Mental Status and Dementia Tests
7
Memantine
7
abemaciclib
5
Blood Specimen Collection
5
Biopsy
4
trastuzumab deruxtecan
3
entrectinib
3
Surveys and Questionnaires
3
Surgical Procedures, Operative
3
Sodium Chloride
3
Saline Solution
3
Receptors, Interleukin-8B
3
Proton Therapy
3
Dexamethasone
3
Cyclophosphamide
3
trametinib
2
pertuzumab
2
osimertinib
2
fluciclovine F-18
2
contrast agent BR1
2
atezolizumab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Brain Neoplasms
×
Azacitidine
×
90 days
×
Clear all
No trials found.